Pegylated liposomal doxorubicin plus bortezomib in relapsed or refractory multiple myeloma: Efficacy and safety in patients with renal function impairment

1. Bladé, J.
2. Sonneveld, P.
3. San Miguel, J.
4. Sutherland, H.
5. Hajek, R.
6. Nagler, A.
7. Spencer, A.
8. Robak, T.
9. Cibeira, M.T.
10. Zhuang, S.
11. Harousseau, J.-L.
12. Orlowski, R.